Survival of patients with elevated AF1q expression
AF1q expression by tertiles . | HR versus first tertile . | P . | Overall survival, %* . | P . |
|---|---|---|---|---|
| First tertile | NA | NA | 59 | .035 |
| Second tertile | 1.4 | .483 | 37 | NA |
| Third tertile | 2.9 | .019 | 19 | NA |
AF1q expression by tertiles . | HR versus first tertile . | P . | Overall survival, %* . | P . |
|---|---|---|---|---|
| First tertile | NA | NA | 59 | .035 |
| Second tertile | 1.4 | .483 | 37 | NA |
| Third tertile | 2.9 | .019 | 19 | NA |
AF1q expression as a continuous variable: HR per fold increase in AF1q expression = 1.02, and P = .32. First tertile versus second tertile, P = .476; second tertile versus third tertile, P = .063; first tertile versus third tertile, P = .026. For the first tertile, N = 22; for the second and third, N = 21.
NA indicates not applicable.
Pairwise comparisons for overall survival.